Title |
Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)
|
---|---|
Published in |
Journal of Experimental & Clinical Cancer Research, October 2008
|
DOI | 10.1186/1756-9966-27-52 |
Pubmed ID | |
Authors |
Evelina Miele, Gian Paolo Spinelli, Federica Tomao, Angelo Zullo, Filippo De Marinis, Giulia Pasciuti, Luigi Rossi, Federica Zoratto, Silverio Tomao |
Abstract |
PET (Positron Emission Tomography) is a nuclear medicine imaging method, frequently used in oncology during the last years. It is a non-invasive technique that provides quantitative in vivo assessment of physiological and biological phenomena. PET has found its application in common practice for the management of various cancers.Lung cancer is the most common cause of death for cancer in western countries.This review focuses on radiotracers used for PET scan with particular attention to Non Small Cell Lung Cancer diagnosis, staging, response to treatment and follow-up. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 1% |
Portugal | 1 | <1% |
Unknown | 164 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 35 | 21% |
Student > Master | 23 | 14% |
Student > Ph. D. Student | 20 | 12% |
Researcher | 7 | 4% |
Student > Doctoral Student | 6 | 4% |
Other | 13 | 8% |
Unknown | 63 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 12% |
Chemistry | 19 | 11% |
Engineering | 14 | 8% |
Physics and Astronomy | 9 | 5% |
Biochemistry, Genetics and Molecular Biology | 9 | 5% |
Other | 30 | 18% |
Unknown | 66 | 40% |